Exploiting the 21st amino acid-purifying and labeling proteins by selenolate targeting

Nature Methods

Volumn 1, Issue 1, 2004, Pages 61-66

  Johansson, Linda ^a   Chen, Chunying ^a,c   Thorell, Jan Olov ^b   Fredriksson, Anna ^b   Stone Elander, Sharon ^b   Gafvelin, Guro ^a   Arner, Elias S J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c INSTITUTE OF HIGH ENERGY PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI PROTEIN; HYBRID PROTEIN; SELENOCYSTEINE;

ARTICLE; CHEMISTRY; ESCHERICHIA COLI; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR CLONING; PROTEIN ENGINEERING; SITE DIRECTED MUTAGENESIS; STAINING;

CLONING, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MUTAGENESIS, SITE-DIRECTED; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; SELENOCYSTEINE; STAINING AND LABELING;

EID: 13844304463     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth707     Document Type: Article

References (34)

1. Kryukov, G.V. et al. Characterization of mammalian selenoproteomes. Science 300, 1439-1443 (2003).
2. Stadtman, T.C. Selenocysteine. Annu. Rev. Biochem. 65, 83–100 (1996).
3. Bock, A. et al. Selenocysteine: The 21st amino acid. Mol. Microbiol. 5, 515-520 (1991).
4. Gieselman, M.D., Zhu, Y., Zhou, H., Galonic, D. & van der Donk, W.A. Selenocysteine derivatives for chemoselective ligations. Chembiochem 3, 709– 716 (2002).
5. Hondal, R.J. & Raines, R.T. Semisynthesis of proteins containing selenocysteine.
6. Methods Enzymol. 347, 70–83 (2002).
7. Lian, G. et al. Preparation and properties of a selenium-containing catalytic antibody as type I deiodinase mimic. J. Biol. Chem. 276, 28037-28041 (2001).
8. Muller, S. et al. The formation of diselenide bridges in proteins by incorporation of selenocysteine residues: Biosynthesis and characterization of (Se)2-thioredoxin. Biochemistry 33, 3404-3412 (1994).
9. Arner, E.S.J., Sarioglu, H., Lottspeich, F., Holmgren, A. & Bock, A. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes. J. Mol. Biol. 292, 10031016 (1999).
10. Gladyshev, V.N., Jeang, K-T. & Stadtman, T.C. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl Acad. Sa’. USA 93, 6146-6151 (1996).
11. Zhong, L., Arner, E.S.J., Ljung, J., Aslund, F. & Holmgren, A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J. Biol. Chem. 273, 8581-8591 (1998).
12. Zhong, L., Arner, E.S.J. & Holmgren, A. Structure and mechanism of mammalian thioredoxin reductase: The active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc. Natl. Acad. Sci. USA 97, 5854-5859 (2000).
13. Nordberg, J., Zhong, L., Holmgren, A. & Arner, E.S.J. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J. Biol. Chem. 273, 10835-10842 (1998).
14. Mutt, V. Vasoactive intestinal polypeptide and related peptides. Isolation and chemistry. Ann. NY Acad. Sci. 527, 1-19 (1988).
15. Simoncsits, A. et al. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide. Eur. J. Biochem. 178, 343-350 (1988).
16. Heymann, P.W., Chapman, M.D., Aalberse, R.C., Fox, J.W. & Platts-Mills, T.A. Antigenic and structural analysis of group II allergens (Der f II and Der p II) from house dust mites (Dermatophagoides spp). J. Allergy Clin. Immunol. 83, 10551067 (1989).
17. Kalef, E., Walfish, P.G. & Gitler, C. Arsenical-based affinity chromatography of vicinal dithiol-containing proteins: Purification of L1210 leukemia cytoplasmic proteins and the recombinant rat c-erb Aß1 T3 receptor. Anal. Biochem. 212, 325-334 (1993).
18. Zhou, G.Y., Jauhiainen, M., Stevenson, K. & Dolphin, P.J. Human plasma lecithin:cholesterol acyltransferase. Preparation and use of immobilized p- aminophenylarsenoxide as a catalytic site-directed covalent ligand in enzyme purification. J. Chromatogr. 568, 69-83 (1991).
19. Hoffman, R.D. & Lane, M.D. Iodophenylarsine oxide and arsenical affinity chromatography: New probes for dithiol proteins. Application to tubulins and to components of the insulin receptor-glucose transporter signal transduction pathway. J. Biol. Chem. 267, 14005-14011 (1992).
20. Muller, S., Heider, J. & Bock, A. The path of unspecific incorporation of selenium in Escherichia coli. Arch. Microbiol. 168, 421-427 (1997).
21. Gespach, C., Bawab, W., de Cremoux, P. & Calvo, F. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Cancer Res. 48, 5079-5083 (1988).
22. Gromer, S., Arscott, L.D., Williams, C.H., Jr, Schirmer, R.H. & Becker, K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J. Biol. Chem. 273, 20096-20101 (1998).
23. Terpe, K. Overview of tag protein fusions: From molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 60, 523-533 (2003).
24. Griffin, B.A., Adams, S.R. & Tsien, R.Y. Specific covalent labeling of recombinant protein molecules inside live cells. Science 281, 269-272 (1998).
25. Adams, S.R. et al. New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: Synthesis and biological applications. J. Am. Chem. Soc. 124, 6063-6076 (2002).
26. Arner, E.S.J. Recombinant expression of mammalian selenocysteine-containing thioredoxin reductase and other selenoproteins in Escherichia coli. Methods Enzymol. 347, 226-235 (2002).
27. Ma, S., Caprioli, R.M., Hill, K.E. & Burk, R.F. Loss of selenium from selenoproteins: Conversion of selenocysteine to dehydroalanine in vitro. J. Am. Soc. Mass Spectrom. 14, 593-600 (2003).
28. Fichna, J. & Janecka, A. Synthesis of target-specific radiolabeled peptides for diagnostic imaging. Bioconjug. Chem. 14, 3-17 (2003).
29. Okarvi, S.M. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur. J. Nucl. Med. 28, 929-938 (2001).
30. Waibel, R. et al. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat. Biotechnol. 17, 897-901 (1999).
31. 2+:nitrilotriacetic acid (n)-fluorochrome conjugates. J. Am. Chem. Soc. 123, 12123-12125 (2001).
32. Chua, K.Y. et al. Isolation of cDNA coding for the major mite allergen Der p II by IgE plaque immunoassay. Int. Arch. Allergy Appl. Immunol. 91, 118-123 (1990).
33. Arner, E.S.J., Zhong, L. & Holmgren, A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol. 300, 226-239 (1999).
34. Said, S.I. & Mutt, V. Isolation from porcine intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur. J. Biochem. 28, 199204 (1972).